Eli Lilly's cholesterol pill impresses in trial

A version of this article first appeared in CNBC's Healthy Returns newsletter, bringing the latest healthcare news directly to your…

What Wall Street is watching

Investors want to know if Eli Lilly is experiencing the same pricing pressures on its blockbuster weight-loss drug Zepbound that…